SURF - Surface Oncology, Inc.
| Previous Close | 1.4000 |
| Open | 1.3800 |
| Bid | 1.0000 x 800 |
| Ask | 1.3900 x 1000 |
| Day's Range | 1.3400 - 1.3800 |
| 52 Week Range | 1.1500 - 9.9400 |
| Volume | 26,251 |
| Avg. Volume | 52,480 |
| Market Cap | 37.33M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3270 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.50 |
- GlobeNewswire
Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City
Keynote speaker: E. John Wherry, Ph.D., director, Penn Institute for Immunology, University of Pennsylvania, and Co-Director of the Parker Institute for Cancer Immunotherapy at.
- Simply Wall St.
Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- ACCESSWIRE
IPO INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 18, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- PR Newswire
Lifshitz & Miller LLP Announces Investigation of Curaleaf Holdings, Inc., Granite Construction, Inc., Karyopharm Therapeutics, Inc., ProPetro Holdings Corp., SAExploration, Inc., Sunnova Energy International, Inc., and Surface Oncology, Inc.
NEW YORK , Sept. 17, 2019 /PRNewswire/ -- Curaleaf Holdings, Inc. (CURLF) Lifshitz & Miller announces investigation into possible securities laws violation in connection with the FDA's warning letter to ...
- GlobeNewswire
Surface Oncology to Present at the Baird 2019 Global Healthcare Conference
CAMBRIDGE, Mass., Sept. 03, 2019 -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor.
- ACCESSWIRE
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 3, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- GlobeNewswire
Ramy Ibrahim, M.D. to Join Surface Oncology Board of Directors
Surface Oncology (SURF), today announced Ramy Ibrahim, M.D., will join the company’s board of directors. Dr. Ibrahim is a medical oncologist currently serving as chief medical officer and vice president of clinical development at the Parker Institute for Cancer Immunotherapy.
- GlobeNewswire
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, Inc. (“Surface” or “the Company”) (NASDAQ: SURF) for false and misleading SEC filings. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
- GlobeNewswire
Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Sunnova Energy on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 27, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against Casa Systems, Inc. (NASDAQ: CASA), Greenlane Holdings, Inc. (NASDAQ: GNLN),.
- ACCESSWIRE
IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 21, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- ACCESSWIRE
URGENT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 20, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- ACCESSWIRE
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 15, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- GlobeNewswire
Bragar Eagel & Squire, P.C. is Investigating Casa Systems, Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 14, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against Casa Systems, Inc. (NASDAQ: CASA), Greenlane Holdings, Inc. (NASDAQ: GNLN),.
- ACCESSWIRE
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 12, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- ACCESSWIRE
URGENT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 8, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- ACCESSWIRE
IMPORTANT INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 7, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
- GlobeNewswire
Bragar Eagel & Squire, P.C. is Investigating Greenlane Holdings, Surface Oncology, and Pintec Technology on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 07, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against Greenlane Holdings, Inc. (NASDAQ: GNLN), Surface Oncology, Inc. (NASDAQ:.
- GlobeNewswire
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, Inc. (“Surface” or “the Company”) (NASDAQ: SURF) for false and misleading SEC filings. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
- Zacks
Surface Oncology, Inc. (SURF) Reports Q2 Loss, Lags Revenue Estimates
Surface Oncology, Inc. (SURF) delivered earnings and revenue surprises of -3.23% and -94.28%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2019
CAMBRIDGE, Mass., Aug. 07, 2019 -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor.
- Zacks
Will Surface Oncology, Inc. (SURF) Report Negative Q2 Earnings? What You Should Know
Surface Oncology, Inc. (SURF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
Shareholder Rights Law Firm Johnson Fistel Launches Investigations
SAN DIEGO , Aug. 3, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims for violations of federal law against the following companies that recently issued ...
- ACCESSWIRE
INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surface Oncology, Inc. and Encourages Investors with Losses in Excess to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 1, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surface Oncology, ...
